| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
3.12 |
Evidence |
|
| ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
PIP3-E |
IPI00103381 |
3.117 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
HHEX |
HHEX, HEX, PRH, PRHX: Homeobox protein PRH |
3.117 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
3.117 |
Evidence |
|
| CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
3.115 |
Evidence |
|
| EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
RPL18A |
RPL18A: 60S ribosomal protein L18a |
3.115 |
Evidence |
|
| P15 |
SUB1, PC4, RPO2TC1: Activated RNA polymerase II transcriptional coactivator p15 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
3.115 |
Evidence |
|
| P15 |
SUB1, PC4, RPO2TC1: Activated RNA polymerase II transcriptional coactivator p15 |
SSRP1 |
SSRP1, FACT80: FACT complex subunit SSRP1 |
3.115 |
Evidence |
|
| FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
3.115 |
Evidence |
O
|
| FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
YBX1 |
YBX1, NSEP1, YB1: Nuclease sensitive element-binding protein 1 |
3.115 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
ARRB2 |
IPI00027355 |
3.115 |
Evidence |
|
| APEX1 |
APEX1, APE, APEX, APX, HAP1, REF1: DNA-(apurinic or apyrimidinic site) lyase |
FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
3.115 |
Evidence |
O
|
| ATF1 |
ATF1: Cyclic AMP-dependent transcription factor ATF-1 |
EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
3.115 |
Evidence |
|
| LAMR1 |
RPSA, LAMBR, LAMR1: 40S ribosomal protein SA |
BCLAF1 |
BTF, BCLAF1, KIAA0164: Bcl-2-associated transcription factor 1 |
3.115 |
Evidence |
|
| RPLP1 |
RPLP1, RRP1: 60S acidic ribosomal protein P1 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
3.115 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
3.115 |
Evidence |
|
| EIF3S7 |
EIF3S7: Eukaryotic translation initiation factor 3 subunit 7 |
EIF3S8 |
EIF3S8: Eukaryotic translation initiation factor 3 subunit 8 |
3.115 |
Evidence |
|
| EIF3S7 |
EIF3S7: Eukaryotic translation initiation factor 3 subunit 7 |
EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
3.115 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
CNGA1 |
CNGA1, CNCG, CNCG1: cGMP-gated cation channel alpha 1 |
3.115 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
KCNN3 |
SK3: Small-conductance calcium-activated potassium channel SK3 |
3.115 |
Evidence |
|
| SMAD9 |
SMAD9, MADH6, MADH9: Mothers against decapentaplegic homolog 9 |
SKI |
SKI: Ski oncogene |
3.115 |
Evidence |
|
| RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
3.112 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
3.112 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
FGL2 |
FGL2: Fibroleukin precursor |
3.112 |
Evidence |
|
| EPOR |
EPOR: Erythropoietin receptor precursor |
SPTA1 |
SPTA1, SPTA: Spectrin alpha chain, erythrocyte |
3.112 |
Evidence |
|